Worsening Disparities in Lupus Nephritis Mortality by Race, Urbanization
Researchers analyzed mortality trends in lupus nephritis in the US from 1999 to 2019 and identified population characteristics associated with mortality.
Lupus Nephritis
Sustained Proteinuria Reductions With Voclosporin in Patients With Lupus Nephritis
In a second interim analysis of the AURORA 2 extension study, researchers reported on the effects of voclosporin on lupus nephritis.
Lupus Nephritis Remission Predicts Good Pregnancy Outcomes
A complete renal remission duration of more than 18 months was associated with good pregnancy outcomes and lower odds of lupus nephritis relapse.
Kidney Function Decline Tied to Death Risk in Lupus Nephritis
Investigators examined mortality in patients with lupus nephritis who had all stages of chronic kidney disease.
Lupus Nephritis in SLE Hospitalizations More Likely Among Minorities
In a study of patients hospitalized with SLE, Black and Hispanic patients and those of other races had higher rates of lupus nephritis compared with White patients, a study found.
Survival Not Worse for Patients With Lupus Who Require KRT
Infection-related mortality appears worse for patients with lupus nephritis.
Short-Term COVID-19 Outcomes Worse in SLE, Lupus Nephritis
Patients with lupus nephritis should be allow early access to COVID-19 vaccination, according to investigators.
Nephrologists, Rheumatologists View LN Treatment Options Differently
In a survey, more rheumatologists than nephrologists viewed belimumab and voclosporin as a “substantial advance” in lupus nephritis treatment.
Voclosporin Demonstrates Efficacy in Severe Lupus Nephritis
Voclosporin acts as an anti-inflammatory agent and also stabilizes podocytes to reduce proteinuria.
Belimumab Effective in Relapsed and Newly Diagnosed Lupus Nephritis
Standard therapy for lupus nephritis achieves complete renal response in only 20% to 40% of patients.
- Loading...
Loading...
Next post in Lupus Nephritis
Loading... 
Loading...